Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
基本信息
- 批准号:9519838
- 负责人:
- 金额:$ 63.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:ART proteinAdultAdverse effectsAgeAgingAnemiaAtherosclerosisBaltimoreBiological AssayBiologyBiometryBlood VesselsBody CompositionBrainCCL11 geneCardiologyCardiovascular DiseasesCause of DeathCessation of lifeClinicalCognitionCognitiveColon CarcinomaCommunitiesCoronary heart diseaseDataDementiaDiagnosisEFRACElderlyEnzyme-Linked Immunosorbent AssayEpidemiologic MethodsErythropoiesisEvaluationExhibitsFSTL3 geneFamilyFollistatinGDF11 geneGDF8 geneGeneral PopulationGeriatricsGoalsGrowth and Development functionHealthHeart HypertrophyHeart failureHomologous GeneHormonesHospitalizationHumanImmunoassayImpaired cognitionInflammatory ResponseInjuryInvestigationLaboratoriesLeft Ventricular MassLongevityLongitudinal StudiesMalignant NeoplasmsMass Spectrum AnalysisMeasuresMemoryMusMuscleMyocardiumNatural regenerationNeurologyOutcomeOxytocinParabiosisPathway interactionsPatternPeptidesPhenotypePhysiologicalPlayProteinsProteomicsProtocols documentationRaceReportingResearch PersonnelRiskRoleScienceSkeletal MuscleSmell PerceptionSpecific qualifier valueSpecificitySpecimenTestingTissuesTransforming Growth Factor betaTranslatingVariantadverse outcomeage relatedaptamerbasebeta-2 Microglobulinbiracialcardiovascular disorder riskcardiovascular healthclinical phenotypecognitive functioncohortdisabilityeffective therapyexperimental studyfollow-uphemodynamicsimprovedinnovationliquid chromatography mass spectrometrymembermortalitymuscle strengthneurogenesisnew therapeutic targetpopulation basedpsychologicpublic health relevancereproductivesexyoung adult
项目摘要
DESCRIPTION (provided by applicant): We propose to test whether mouse experiments showing that circulating proteins can rejuvenate or accelerate aging in the brain, heart, and skeletal muscle translate into corresponding associations with important clinical outcomes in older adults. Using an assay for GDF11 that has since been determined also to measure its close structural homologue, GDF8, we demonstrated in preliminary studies that these geronic proteins are associated with incident heart failure (HF) and atherosclerotic cardiovascular disease (ASCVD) in cohorts with prevalent coronary disease. By contrast, follistatin-like 3, an antagonist of GDF11 and GDF8, exhibited the opposite associations. These findings highlight the need to identify more specific assays, and they also call for broader investigation of relevant
pathways in general population-based cohorts. We will therefore undertake systematic comparisons of state-of-the-art LC mass spectroscopy, aptamer-based proteomics, and immunoassays to select the best assay for each protein. We will then harness the comprehensive clinical phenotyping and exceptional statistical power of two large, biracial cohorts, the Cardiovascular Health Study and the Health Aging, and Body Composition Study to efficiently test the following hypotheses. First, that higher levels of CCL11 and of ß2 microglobulin, which decrease neurogenesis in mice, are associated with impaired cognitive function and increased risk of dementia. Second, that as in mice, higher levels of GDF11 are associated with lower left ventricular (LV) mass and reduced risk of heart failure, particularly with preserved ejection fraction (HFpEF), ASCVD, and risk of dementia. Third, that higher levels of GDF11 and oxytocin are associated with improved skeletal muscle strength and reduced risk of mobility disability. Beyond these endpoints, we will also examine various adverse outcomes. Moreover, we will describe how levels of these proteins vary across the lifespan, from age 20 to 96, using data and specimens from the Baltimore Longitudinal Study of Aging. These data will enable us to analyze how levels of these proteins influence cognition, LV mass, and muscle strength across the life span. The proposed study will be led by a coordinated team of PIs and investigators who are leaders in their fields of laboratory science, geriatrics, cardiology, neurology, muscle and mobility, and biostatistics. An exceptional Scientific Advisory board of leaders in parabiosis and the basic biology of these proteins has and will continue to inform our choices of peptides and phenotypes, and guide analyses of our data. Hence, the proposed study will provide a comprehensive analysis of these exciting proteins in human cohorts with the aim of identifying novel therapeutic targets for major causes of disability and mortality for which
few effective treatments are currently available.
描述(由申请人提供):我们建议测试小鼠实验是否表明循环蛋白质可以使大脑,心脏和骨骼肌恢复活力或加速衰老,并将其转化为与老年人重要临床结果的相应关联。使用GDF11的测定,该测定也被确定用于测量其密切的结构同源物GDF8,我们在初步研究中证明,这些老年蛋白与流行性冠状动脉疾病队列中的偶发性心力衰竭(HF)和动脉粥样硬化性心血管疾病(ASCVD)相关。相比之下,卵泡抑素样3,GDF11和GDF8的拮抗剂,表现出相反的关联。这些发现强调了需要确定更具体的检测方法,他们还呼吁对相关的
在一般人群为基础的队列的途径。因此,我们将进行最先进的LC质谱,基于适体的蛋白质组学和免疫测定的系统比较,以选择每种蛋白质的最佳测定。然后,我们将利用综合临床表型和两个大型birthday队列,心血管健康研究和健康老龄化和身体成分研究的特殊统计能力,有效地测试以下假设。首先,CCL11和β 2微球蛋白水平升高会降低小鼠的神经发生,与认知功能受损和痴呆风险增加有关。第二,在小鼠中,较高水平的GDF11与较低的左心室(LV)质量和降低的心力衰竭风险相关,特别是与保留射血分数(HFpEF),ASCVD和痴呆风险相关。第三,更高水平的GDF11和催产素与骨骼肌力量的改善和移动残疾风险的降低有关。除了这些终点,我们还将检查各种不良结局。此外,我们将描述这些蛋白质的水平如何在整个生命周期中变化,从20岁到96岁,使用来自巴尔的摩老龄化纵向研究的数据和标本。这些数据将使我们能够分析这些蛋白质的水平如何影响整个生命周期的认知,LV质量和肌肉力量。拟议的研究将由PI和研究人员组成的协调团队领导,他们是实验室科学,老年病学,心脏病学,神经病学,肌肉和移动性以及生物统计学领域的领导者。一个由联体共生和这些蛋白质的基础生物学领导者组成的特殊科学咨询委员会已经并将继续为我们选择肽和表型提供信息,并指导我们的数据分析。因此,拟议的研究将提供对人类队列中这些令人兴奋的蛋白质的全面分析,目的是为残疾和死亡的主要原因确定新的治疗靶点,
目前几乎没有有效的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN RON CUMMINGS其他文献
STEVEN RON CUMMINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN RON CUMMINGS', 18)}}的其他基金
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
- 批准号:
10170192 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Prevention of Fractures in Patients with Parkinson's Disease
帕金森病患者骨折的预防
- 批准号:
10617169 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Study of Muscle, Mobility and Aging: SOMMA2
肌肉、活动能力和衰老研究:SOMMA2
- 批准号:
10913728 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
- 批准号:
10441623 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
- 批准号:
10015194 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
- 批准号:
10652212 - 财政年份:2018
- 资助金额:
$ 63.5万 - 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
- 批准号:
9279037 - 财政年份:2016
- 资助金额:
$ 63.5万 - 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins - SUPPLEMENT
衰老相关临床结果和老年蛋白的综合评估 - 补充材料
- 批准号:
9445352 - 财政年份:2016
- 资助金额:
$ 63.5万 - 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
- 批准号:
9119555 - 财政年份:2016
- 资助金额:
$ 63.5万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 63.5万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 63.5万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 63.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 63.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 63.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)